The use of Yarrowia lipolytica for the expression of human cytochrome P450 CYP1A1
Open Access
- 30 April 2004
- Vol. 21 (7) , 583-592
- https://doi.org/10.1002/yea.1127
Abstract
Cytochromes P450 constitute a superfamily of haem‐thiolate mono‐oxygenases that are involved in the oxidative metabolism of lipophilic subtrates. These enzymes require association with cytochrome P450 reductase (CPR) to achieve optimal activities. We have expressed human cytochrome P450 CYP1A1 under the POX2 promoter (pPOX2–CYP1A1) in Y. lipolytica, with or without overproduction of Y. lipolytica CPR expressed under the ICL promoter (pICL–CPR) or the POX2 promoter (pPOX2–CPR). Activity of cytochrome CYP1A1 was analysed by conversion of hydroxyresorufin to resorufin. Strain JMY330 and JMY330–CPR present no activity, the monocopy cytochrome CYP1A1 integrant JMY331 and JMY331–CPR derivatives present an average activity of 32.0 pM/min/dw and 48.3 and 64.6 pM/min/dw for pICL–CPR and pPOX2–CPR, respectively. Increase of CPR expression resulted in about two‐fold higher activity. The multicopy 1A1 integrant JMY339 and JMY339–CPR derivatives present an activity of 129 pM/min/dw and 815–1845 pM/min/dw, respectively. Increase of CPR expression resulted in 6.3–12.8‐fold higher activity, depending on the CPR transformant. We observed a 50‐fold increase of activity between the monocopy integrant JMY331 as compared to the multicopies integrant JMY339–CPR in which CPR was overexpressed. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 37 references indexed in Scilit:
- Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug MetabolismClinical Pharmacokinetics, 2003
- Cytochrome P450-based cancer gene therapy: current statusExpert Opinion on Biological Therapy, 2002
- Protein expression and secretion in the yeastYarrowia lipolyticaFEMS Yeast Research, 2002
- Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/ insect cell systemXenobiotica, 2001
- Comparison of promoters suitable for regulated overexpression of β-galactosidase in the alkane-utilizing yeastYarrowia lipolyticaBiotechnology and Bioprocess Engineering, 2000
- Lack of Electron Transfer from Cytochrome b5 in Stimulation of Catalytic Activities of Cytochrome P450 3A4Journal of Biological Chemistry, 1996
- Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5Gene, 1993
- Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymesEuropean Journal of Biochemistry, 1993
- Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cellsBiochimie, 1990
- Genetically Engineered P450 Monooxygenases: Construction of Bovine P450c17/Yeast Reductase Fused EnzymesDNA and Cell Biology, 1990